IceCure Medical Ltd Stock TEL AVIV STOCK EXCHANGE
Stocks
ICCM
IL0011224156
Advanced Medical Equipment & Technology
| Market Cap | 18.09M 0 15.88M 14.62M 13.62M 25.69M 1.72B 26.22M 176M 68.13M 844M 67.93M 66.46M 2.94B | P/E 2026 * |
-0.93x | P/E 2027 * | -1.36x |
|---|---|---|---|---|---|
| Enterprise Value | 18.09M 0 15.88M 14.62M 13.62M 25.69M 1.72B 26.22M 176M 68.13M 844M 67.93M 66.46M 2.94B | EV / Sales 2026 * |
2.84x | EV / Sales 2027 * | 1.44x |
| Free-Float |
60.06% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: IceCure Medical Ltd
| Manager | Title | Age | Since |
|---|---|---|---|
Eyal Shamir
CEO | Chief Executive Officer | 65 | 2016-08-31 |
Meir Peleg
DFI | Director of Finance/CFO | 50 | 2026-05-16 |
Shay Levav
COO | Chief Operating Officer | 49 | 2025-11-04 |
| Director | Title | Age | Since |
|---|---|---|---|
Chun Hung Chan
BRD | Director/Board Member | 62 | 2022-12-03 |
Sharon Levita
BRD | Director/Board Member | 57 | 2019-08-31 |
Yonatan Malca
BRD | Director/Board Member | 60 | 2025-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -6.22% | - | - | 18.09M | |
| +2.39% | +4.29% | +21.80% | -1.61% | 191B | |
| +1.18% | +0.14% | -25.21% | +17.68% | 143B | |
| +1.70% | +2.57% | -3.67% | -19.28% | 137B | |
| +0.89% | -3.15% | -58.90% | -20.39% | 64B | |
| +1.69% | +2.60% | +19.19% | -2.48% | 52.97B | |
| -0.97% | -0.90% | -28.11% | -32.73% | 43.82B | |
| +0.42% | +1.34% | +10.74% | +10.93% | 37.67B | |
| +0.82% | +2.42% | +5.91% | +41.87% | 37.13B | |
| +1.33% | -0.03% | -14.60% | -20.16% | 29.5B | |
| Average | +0.94% | +2.37% | -8.10% | -2.91% | 81.72B | |
| Weighted average by Cap. | +1.42% | +3.37% | -5.07% | -2.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.37M 0 5.59M 5.15M 4.8M 9.05M 606M 9.23M 61.91M 23.99M 297M 23.92M 23.4M 1.03B | 12.55M 0 11.01M 10.14M 9.45M 17.82M 1.19B 18.18M 122M 47.25M 585M 47.1M 46.09M 2.04B |
| Net income | -16.63M -0 -14.6M -13.44M -12.52M -23.62M -1.58B -24.1M -162M -62.62M -776M -62.43M -61.08M -2.7B | -14.06M -0 -12.34M -11.36M -10.59M -19.96M -1.34B -20.37M -137M -52.94M -656M -52.78M -51.64M -2.28B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
